Sharon R. Flanagan
Advertisement
Sharon R. Flanagan is a partner at Sidley Austin LLP across life sciences M&A and FDA regulatory practice.
Articles by Sharon R. Flanagan
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
FDA Pannel Votes to Loosen Restrictions for Four Peptides
2
Pharmaceutical Executive Daily: FDA Votes to Reduce Restrictions on Four Peptides
3
President Trump Announces Phased Generic Drug Tariff Plan: Report
4
Retatrutide Delivers Up to 22.6% Weight Loss in Two New Phase III Trials
5